Disease modifying anti-rheumatic drugs (DMARDs) are used to treat a range of inflammatory and autoimmune conditions by reducing disease activity and preventing long-term complications. This page provides information on the safe use, monitoring and management of DMARD therapy.
Hydroxycarbamide is used in the management of myeloproliferative neoplasms and other selected haematological conditions. This page provides information to support the safe and effective use of hydroxycarbamide, including monitoring requirements and ongoing patient care.
